Tech Company Financing Transactions
CeraPedics Funding Round
CeraPedics closed a $19 million Series C funding round on 12/12/2012. Backers included CVF, MedImmune Ventures and NGN Capital.
Transaction Overview
Company Name
Announced On
12/12/2012
Transaction Type
Venture Equity
Amount
$19,000,000
Round
Series C
Proceeds Purpose
Proceeds will be used to support the company's ongoing activities with its current Investigational Device Exemption (IDE) clinical trial in the United States studying its i-FACTOR(TM) peptide enhanced bone graft for cervical spine applications and prepare for commercialization upon FDA approval.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
11025 Dover St. 1600
Westminster, CO 80021
USA
Westminster, CO 80021
USA
Phone
Website
Email Address
Overview
At Cerapedics, we are focused on developing and commercializing novel osteobiologic products based on a proprietary small peptide technology (P-15) on anorganic bone mineral (ABM), supported by the highest level of clinical evidence, and validated in clinically relevant real world applications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Glen Kashuba
Chief Financial Officer
Drew Trivisonno
Chief Operating Officer
Jeff Marx
VP - Bus. Development
Andrew Woods
VP - Marketing
Scott Johnson
VP - R & D
Jerome Connor
VP - Regulatory Affairs
Roger White
VP - Sales
Andrew Barnes
Browse more venture capital transactions:
Prev: 12/12/2012: Ensenda venture capital transaction
Next: 12/12/2012: MyEdGPS venture capital transaction
Share this article
About Our Venture Capital Transactions Database
We do our best to document all VC transactions involving tech companies. VC investment data records reported here are derived from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs